Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Seqens
19 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
PAP-Q4-20-CL-025
Investment
SEQENS Invests in New Technologies
PR-M11-20-015
Leadership
Seqens CDMO North America Appoints Jean-Noel David as Managing Director
PR-M09-20-21
SEQENS Inaugurates HPAPI Unit
PR-M08-20-NI-47
COVID-19
SEQENS Mobilizes its Innovation to Support the Unprecedented Research on COVID-19 and Prepares its Unique Industrial Network for Anti-Virus Production, for Example Hydroxychloroquine
PR-M05-20-NI-005
Biopharma
Evolution is Essential in the Dynamic Pharmaceutical Industry
PAP-Q1-20-CL-033
Generics
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
PR-M01-20-NI-021
Capacity Expansion
Seqens to Unveil New Innovation and Development Center of Excellence
PR-M06-19-NI-019
Chiral Synthesis
Applying Enzymatic Synthesis for Chiral Molecules
PAP-Q2-2019-CL-029
Drug Development
Glycuron™ 2.78 Able to Enhance Measurable Positive Image Perception
PR-M04-19-NI-019
Probiotics
Megabiotic™-44, a Pre and Postbiotics Complex, from Lactobacillus Bulgaricus GLB44, Microorganism Able to Enhance Pore Refinement
PR-M04-19-NI-018
Launch
Seqens Cosmetics, Functional Care (formerly Chemoxy), Launches ChemoxyCare® 6, 1,2- Hexanediol with Best in Class Quality Profile
PR-M04-19-NI-017
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
PAO-M03-19-NI-024
HPAPI
Investing in the Future of Potent Compounds
PAP-Q1-2019-CL-028
Artificial Intelligence
Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?
PAP-Q1-2019-NI-002
Serialization
PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements
PAO-M03-18-NI-008
Serialization
PCI Pharma Services Announces Release of Joint White Paper with Domino on Ink Leachability in Pharmaceutical Serialization
PR-M09-17-NI-008
Partnership
PCI Announces Further Investment in Specialized Labeling Capabilities
PR-M08-17-NI-011
Capacity
PCI Pharma Services Announces Expansion of Cold Chain Capacity at Philadelphia Site
PR-M08-17-NI-010
